Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - COST OF REVENUE
Cost of Revenue YMAB - Y-mAbs Therapeutics, Inc.
11.4 M
LAST VALUE
113.10%
2 YEAR CAGR
230.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR